Lonza Group AG LZAGY
81.44 USD +2.29 (+2.89%)
Nov 4, 2026, 3:59 PM EST
80.65 Day range 81.50
58.53 52-week range 81.50
- YTD
- +21.21%
- 1 year
- +22.89%
- Market cap
- 57.95B
- EPS (ttm)
- 1.90
- P/E ratio
- 42.86
- YTD return
- +21.21%
- 1-year return
- +22.89%
- Volume
- 3.95K
- Avg volume
- 41.78K
- Open
- 81.30
- Previous close
- 79.15
- Day's range
- 80.65 – 81.50
- 52-week range
- 58.53 – 81.50
- Earnings date
- Jul 22, 2026
6M +18.67 (+29.78%)
Next earnings
Jul 22, 2026
Expected Jul 22, 2026. Consensus EPS estimate 1.07.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jul 22, 2026 | Jun 30, 2026 | 1.07 | — | — | — |
| Jan 28, 2026 | Dec 31, 2025 | 1.19 | 1.07 | -0.12 | -10.08% |
| Jul 23, 2025 | Jun 30, 2025 | 0.869 | 0.764 | -0.10 | -12.08% |
| May 14, 2025 | Dec 31, 2024 | 0.881 | 0.4741 | -0.41 | -46.19% |
| Jul 25, 2024 | Jun 30, 2024 | 4.90 | 0.515 | -4.39 | -89.49% |
| Jan 29, 2024 | Dec 31, 2023 | 8.02 | 0.3922 | -7.63 | -95.11% |
News
Lonza Group AG (LZAGY) Discusses Acquisition of U.S. CDMO Facilities to Expand Bioconjugation and Biovector Capabilities Transcript 
Lonza Group AG (LZAGY) Analyst/Investor Day Transcript 
Lonza Group Ag (OTCMKTS:LZAGY) Short Interest Update 
Lonza Group AG (LZAGY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript 
Lonza: Strong H1 Execution, Higher Guidance Means Higher Upside 
Lonza Group AG (LZAGY) Q2 2026 Earnings Call Transcript 
PAHC or LZAGY: Which Is the Better Value Stock Right Now? 
Lonza Group AG (LZAGY) Q1 2026 Earnings Call Transcript 
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products 
Lonza: Structural Growth Intact, CHI Exit Strengthens Focus, Recent Weakness Reinforces Entry Opportunity
Your note
Sign in to keep a note on LZAGY — it syncs with the Stock Master app.